Clinical Trials
Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE Phase 3 clinical trials, evaluating the safety and efficacy of MK-8527, an investigational once-monthly, oral nucleoside reverse transcriptase translocation...
Drug Research
China Unveils Innovative Drugs Policy to Boost Development
The National Health Commission and China's National Healthcare Security Administration (NHSA) together unveiled a comprehensive new policy on June 30 called "Several Measures to Support the High-Quality Development of Innovative Drugs". The policy, which was formally unveiled to the...
Drug Research
Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines
London, 28 June 2025 – In its ongoing mission to help meet America’s growing need for high-quality US-made medicines, Hikma Pharmaceuticals USA today announces it will invest $1 billion by 2030 to further expand its US manufacturing and R&D...
BioPharma
Biopharma Production with AI: A New Era in Manufacturing
A New Era of Biopharma Production with AI
The biopharma industry is undergoing a transformation as it capitalises on the potential of artificial intelligence (AI) to revolutionise production processes. Manufacturers are currently facing the most significant challenge in history: the...
BioPharma
AI Drug Discovery Transforming APAC Biopharma Innovation
The Asia-Pacific (APAC) biopharmaceutical space is being revolutionized by the tremendous progress made in artificial intelligence (AI). The use of AI technologies to drive drug discovery is not just a fad but a paradigm shift transforming the way new...
BioPharma
Projected Growth of Injectable Drug Market To $1139B By 2029
According to a recent analysis released by MarketsandMarkets, the injectable medication delivery market is expected to grow at a compound annual growth rate (CAGR) of about 9% between 2024 and 2029.
By 2029, this market is projected to be worth...
Drug Research
Viva Biotech Launches the AI-Driven Drug Discovery Platform, Transforming New Drug R&D Logic, Enabling One-Stop Innovative Drug Discovery
Artificial intelligence has rapidly evolved from academic theory into a transformative force in pharmaceutical R&D. From early QSAR models to neural networks, and now to AlphaFold3, AI has progressively unlocked deeper biological insights. By integrating structure prediction, molecular modeling,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read